Eversept Partners, LP Taro Pharmaceutical Industries LTD Transaction History

Eversept Partners, LP

  • $1.26 Billion
  • Q3 2024

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$40.97 - $43.33 $309,446 - $327,271
7,553 Added 2.95%
263,541 $11.2 Million
Q4 2023

Feb 14, 2024
BUY
$32.77 - $42.31 $21,792 - $28,136
665 Added 0.26%
255,988 $10.7 Million
Q3 2023

Nov 14, 2023
BUY
$35.46 - $40.13 $178,612 - $202,134
5,037 Added 2.01%
255,323 $9.63 Million
Q2 2023

Nov 08, 2023
BUY
$24.24 - $40.97 $121,660 - $205,628
5,019 Added 2.05%
250,286 $9.49 Million
Q2 2023

Aug 14, 2023
BUY
$24.24 - $40.97 $121,660 - $205,628
5,019 Added 2.05%
250,286 $9.49 Million
Q1 2023

Nov 08, 2023
BUY
$23.0 - $31.59 $455,515 - $625,639
19,805 Added 8.78%
245,267 $5.96 Million
Q1 2023

May 15, 2023
BUY
$23.0 - $31.59 $455,515 - $625,639
19,805 Added 8.78%
245,267 $5.96 Million
Q4 2022

Nov 08, 2023
BUY
$27.6 - $32.99 $57,380 - $68,586
2,079 Added 0.93%
225,462 $6.55 Million
Q4 2022

Feb 14, 2023
BUY
$27.6 - $32.99 $57,380 - $68,586
2,079 Added 0.93%
225,462 $6.55 Million
Q3 2022

Nov 08, 2023
BUY
$28.74 - $39.9 $86,018 - $119,420
2,993 Added 1.36%
223,383 $6.7 Million
Q3 2022

Nov 14, 2022
BUY
$28.74 - $39.9 $86,018 - $119,420
2,993 Added 1.36%
223,383 $6.7 Million
Q2 2022

Nov 08, 2023
BUY
$35.0 - $43.59 $3,640 - $4,533
104 Added 0.05%
220,390 $7.97 Million
Q2 2022

Aug 15, 2022
BUY
$35.0 - $43.59 $3,640 - $4,533
104 Added 0.05%
220,390 $7.97 Million
Q1 2022

Nov 08, 2023
SELL
$43.12 - $50.3 $1.29 Million - $1.51 Million
-30,000 Reduced 11.99%
220,286 $9.53 Million
Q1 2022

May 16, 2022
BUY
$43.12 - $50.3 $1.69 Million - $1.97 Million
39,135 Added 21.6%
220,286 $9.53 Million
Q4 2021

Nov 08, 2023
BUY
$47.6 - $65.0 $84,966 - $116,025
1,785 Added 1.0%
181,151 $9.08 Million
Q4 2021

Feb 14, 2022
BUY
$47.6 - $65.0 $84,966 - $116,025
1,785 Added 1.0%
181,151 $9.08 Million
Q3 2021

Nov 08, 2023
BUY
$62.34 - $73.38 $318,993 - $375,485
5,117 Added 2.94%
179,366 $11.4 Million
Q3 2021

Nov 15, 2021
BUY
$62.34 - $73.38 $318,993 - $375,485
5,117 Added 2.94%
179,366 $11.4 Million
Q2 2021

Nov 08, 2023
BUY
$70.26 - $76.64 $693,536 - $756,513
9,871 Added 6.01%
174,249 $12.5 Million
Q2 2021

Aug 16, 2021
BUY
$70.26 - $76.64 $693,536 - $756,513
9,871 Added 6.01%
174,249 $12.5 Million
Q1 2021

Nov 08, 2023
BUY
$70.48 - $79.95 $854,358 - $969,153
12,122 Added 7.96%
164,378 $12.1 Million
Q1 2021

May 13, 2021
BUY
$70.48 - $79.95 $854,358 - $969,153
12,122 Added 7.96%
164,378 $12.1 Million
Q4 2020

Nov 08, 2023
SELL
$54.4 - $73.42 $5.33 Million - $7.2 Million
-98,030 Reduced 39.17%
152,256 $11.2 Million
Q4 2020

Feb 16, 2021
BUY
$54.4 - $73.42 $563,964 - $761,145
10,367 Added 7.31%
152,256 $11.2 Million
Q3 2020

Nov 08, 2023
BUY
$54.41 - $68.2 $2 Million - $2.5 Million
36,720 Added 34.92%
141,889 $7.78 Million
Q3 2020

Nov 13, 2020
BUY
$54.41 - $68.2 $2 Million - $2.5 Million
36,720 Added 34.92%
141,889 $7.78 Million
Q2 2020

Nov 08, 2023
BUY
$61.66 - $70.16 $1.77 Million - $2.01 Million
28,710 Added 37.55%
105,169 $6.99 Million
Q2 2020

Aug 13, 2020
BUY
$61.66 - $70.16 $1.77 Million - $2.01 Million
28,710 Added 37.55%
105,169 $6.99 Million
Q1 2020

Nov 08, 2023
BUY
$59.35 - $88.73 $4.24 Million - $6.34 Million
71,506 Added 1443.69%
76,459 $4.68 Million
Q1 2020

May 13, 2020
BUY
$59.35 - $88.73 $4.24 Million - $6.34 Million
71,506 Added 1443.69%
76,459 $4.68 Million
Q4 2019

Nov 08, 2023
SELL
$74.18 - $97.92 $18.2 Million - $24 Million
-245,333 Reduced 98.02%
4,953 $435,000
Q4 2019

Feb 13, 2020
BUY
$74.18 - $97.92 $367,413 - $484,997
4,953 New
4,953 $436,000

Others Institutions Holding TARO

# of Institutions
9
Shares Held
17K
Call Options Held
0
Put Options Held
0
View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

TARO Quotes by TradingView
  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email